Bausch + Lomb has been
granted US Food and Drug
Administration approval forits
Prolensa (bromfenac opthalmic
solution) 0.07%.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Apr 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Apr 13
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.